Jean–Frédéric Colombel

13.4k citations

75 papers · 8.9k indexed · 6 hit papers · h-index 35

Genetics top 0.05%
- Inflammatory Bowel Disease 68
Gastroenterology top 0.5%
- Gastrointestinal motility and disorders 4
Epidemiology top 0.2%
- Microscopic Colitis 48
- Autoimmune and Inflammatory Disorders 8
Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 9
Surgery top 1%
- Eosinophilic Esophagitis 12
- Helicobacter pylori-related gastroenterology studies 8
- Diagnosis and treatment of tuberculosis 4

Co-authors: William J. Sandborn Laurent Peyrin‐Biroulet Stefan Schreiber Simon Travis Bruce E. Sands Paul Rutgeerts Remo Panaccione Paul F. Pollack
Cited by: Genetics Gastroenterology Epidemiology
Partner nations: France United States Canada

In The Last Decade

Jean–Frédéric Colombel

67 papers receiving 8.7k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2019 Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
2012 Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012 Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2011 Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
2006 Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

Peers

Countries citing papers authored by Jean–Frédéric Colombel

Since Specialization

Citations

This map shows the geographic impact of Jean–Frédéric Colombel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean–Frédéric Colombel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean–Frédéric Colombel more than expected).

Fields of papers citing papers by Jean–Frédéric Colombel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean–Frédéric Colombel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean–Frédéric Colombel. The network helps show where Jean–Frédéric Colombel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jean–Frédéric Colombel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jean–Frédéric Colombel Line = papers co-authored together Jean–Frédéric Colombel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Benefit–risk profile of upadacitinib: exploratory post hoc analysis of phase 2b/3 studies in patients with moderately to severely active ulcerative colitis or Crohn’s disease Séverine Vermeire,Jean–Frédéric Colombel,Silvio Danese,Remo Panaccione,Laurent Peyrin‐Biroulet,Kendall Beck,María Chaparro,Javier P. Gisbert,Elena Dubcenco,Justin Klaff,Grace Naling,Sharanya Ford,Valencia P. Remple,Namita Joshi,Smitha Suravaram,Benjamin Duncan,Yibo Wang,Bettina Wick-Urban,Edward V. Loftus	2025	0
2	Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies Remo Panaccione,Édouard Louis,Jean–Frédéric Colombel,Geert D’Haens,Laurent Peyrin‐Biroulet,Marla Dubinsky,Ken Takeuchi,David T. Rubin,Jasmina Kalabic,Karen B. Chien,Su Chen,Ling Cheng,Yafei Zhang,W. Rachel Duan,Ramona Vladea,Patrick Hecht,Pierre Morisset,Stefan Schreiber,Marc Ferrante	2025	5
3	Scoring indices for assessing endoscopic disease activity in acute severe ulcerative colitis: a systematic review Hadar Meringer,Maia Kayal,Vipul Jairath,Anila Qasim,John K MacDonald,Yuhong Yuan,Christopher Ma,Jean–Frédéric Colombel	2025	0
4	Intravenous Steroids Do Not Improve Short-Term Outcomes of Patients With Crohn’s Disease Presenting With an Acute Small Bowel Obstruction Mariely Garcia,Anketse Debebe,Farhan Mahmood,Sharon Nirenberg,Alexa Rendon,Eun-Young Yang,Jiani Xiang,Jean–Frédéric Colombel,Tamara F. Kahan,Ghoncheh Ghiasian,Adam S. Faye,Irving Levine,Michael J. Farber,Michael Ramada,Tisor Omoakhe,Keith Sultan,David B. Sachar	2024	0
5	S1127 A Randomized, Double-Blind, Placebo-Controlled Trial of Vedolizumab With and Without Upadacitinib in Adults With Crohn’s Disease: Design and Rationale for the VICTRIVA Study Silvio Danese,Bruce E. Sands,Brian G. Feagan,Vipul Jairath,Remo Panaccione,Laurent Peyrin‐Biroulet,Peter M. Irving,S Schreiber,Iris Dotan,Marc Ferrante,Geert D’Haens,Stephen L. Jones,Marcelo Freire,Dirk Lindner,Shashi Adsul,P. Oberai,Jean–Frédéric Colombel	2024	0
6	A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities Noa Krugliak Cleveland,Brian Bressler,Corey A. Siegel,Leonard Baidoo,Adam S. Cheifetz,Jean–Frédéric Colombel,Parakkal Deepak,Shane Devlin,Peter M. Irving,Gil Melmed,Laura E. Raffals,Florian Rieder,David T. Rubin,Miles Sparrow,Joana Torres,Thomas Ullman,Fernando Velayos	2022	6
7	Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis Neeraj Narula,Emily C L Wong,Jean–Frédéric Colombel,Robert H. Riddell,John K. Marshall,Walter Reinisch,Parambir S. Dulai	2021	26
8	Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn’s Disease: An IOIBD Initiative Silvio Danese,Gionata Fiorino,Jean-Yves Mary,Péter L. Lakatos,Geert D’Haens,Lorenzo Moja,André D’Hoore,Julián Panés,Walter Reinisch,William J. Sandborn,Simon Travis,Séverine Vermeire,Laurent Peyrin‐Biroulet,Jean–Frédéric Colombel	2015	79
9	Management of Severe Ulcerative Colitis Neeraj Narula,Bindia Jharap,Jean–Frédéric Colombel	2015	2
10	Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice Barrett G. Levesque,William J. Sandborn,Joannie Ruel,Brian G. Feagan,Bruce E. Sands,Jean–Frédéric Colombel	2014	156
11	Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud,Alexander C. Ford,Émilie Del Tedesco,Jean–Frédéric Colombel,Xavier Roblin,Laurent Peyrin‐Biroulet	2013	143
12	Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study Cloé Charpentier,Julia Salleron,Guillaume Savoye,Mathurin Fuméry,V. Merle,Jean-Eric Labérenne,Francis Vasseur,Jean‐Louis Dupas,Antoine Cortot,Luc Dauchet,Laurent Peyrin‐Biroulet,Éric Lerebours,Jean–Frédéric Colombel,Corinne Gower‐Rousseau	2013	252
13	Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol Xavier Hébuterne,Marc Lémann,Yoram Bouhnik,Olivier Dewit,Jean‐Louis Dupas,Michael Mroß,Geert D’Haens,Krassimir Mitchev,Étienne Ernault,Séverine Vermeire,Hedia Brixi‐Benmansour,Tom G. Moreels,Jean–Yves Mary,Philippe Marteau,Jean–Frédéric Colombel	2012	129
14	Genotype/Phenotype Analyses for 53 Crohn’s Disease Associated Genetic Polymorphisms Camille Jung,Jean–Frédéric Colombel,Marc Lémann,Laurent Beaugerie,Matthieu Allez,Jacques Cosnes,Gwénola Vernier-Massouille,Jean‐Marc Gornet,Jean–Pierre Gendre,Jean‐Pierre Cézard,Frank M. Ruemmele,Dominique Turck,Françoise Merlin,Habib Zouali,Christian Libersa,Philippe Dieudé,Nadem Soufir,Gilles Thomas,Jean‐Pierre Hugot	2012	42
15	Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current managementbreakdown → Axel Dignaß,James O. Lindsay,Andreas Sturm,Alastair Windsor,Jean–Frédéric Colombel,Matthieu Allez,Gert D'Haens,André D’Hoore,Gerassimos J. Mantzaris,Gottfried Novacek,Tom Öresland,Walter Reinisch,Miquel Sans,Eduard F. Stange,Séverine Vermeire,Simon Travis,Gert Van Assche	2012	1248
16	Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)breakdown → Simon Travis,Dan Schnell,Piotr Krzeski,María T. Abreu,Douglas G. Altman,Jean–Frédéric Colombel,Brian G. Feagan,Stephen B. Hanauer,Marc Lémann,Gary R. Lichtenstein,Phillippe R Marteau,Walter Reinisch,Bruce E. Sands,Bruce Yacyshyn,Christian A. Bernhardt,Jean–Yves Mary,William J. Sandborn	2011	441
17	Optimizing treatment and minimizing adverse events Bénédicte De Vroey,Jean–Frédéric Colombel	2011	13
18	Clinical implications of mucosal healing for the management of IBD Guillaume Pineton de Chambrun,Laurent Peyrin‐Biroulet,Marc Lémann,Jean–Frédéric Colombel	2009	368
19	Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trialbreakdown → Jean–Frédéric Colombel,William J. Sandborn,Paul Rutgeerts,Robert Enns,Stephen B. Hanauer,Remo Panaccione,Stefan Schreiber,Dan Byczkowski,Ju Li,Jeffrey D. Kent,Paul F. Pollack	2006	1655
20	Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis Pierre-Eugène Mortier,L Gambiez,M Karoui,Antoine Cortot,J Paris,P Quandallé,Jean–Frédéric Colombel	2006	55

About Jean–Frédéric Colombel

Jean–Frédéric Colombel is a scholar working on Genetics, Gastroenterology and Epidemiology, having authored 75 papers that have together received 8.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (68 papers), Microscopic Colitis (48 papers), Eosinophilic Esophagitis (12 papers), Immunodeficiency and Autoimmune Disorders (9 papers), Autoimmune and Inflammatory Disorders (8 papers), Helicobacter pylori-related gastroenterology studies (8 papers), Gastrointestinal motility and disorders (4 papers) and Diagnosis and treatment of tuberculosis (4 papers). The work is most often cited by research in Genetics (7.0k citations), Gastroenterology (951 citations) and Epidemiology (5.5k citations). Jean–Frédéric Colombel has collaborated with scholars based in France, United States and Canada. Frequent co-authors include William J. Sandborn, Laurent Peyrin‐Biroulet, Stefan Schreiber, Simon Travis, Bruce E. Sands, Paul Rutgeerts, Remo Panaccione, Paul F. Pollack, Ju Li and Stephen B. Hanauer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact